Mr. Dunaway is being recognized by Integrated Medical Foundation (IMF) at their annual Bruce Morrell Comedy for a Cause, being held at the Woodbury Jewish Center, May 9, 2012. He is the first non-physician to be honored by IMF for his contributions to education in the battle against prostate cancer.

http://www.ncbi.nlm.nih.gov/pubmed/22035764

The interviews were aired on the Jets pre-game show on ESPN Sports Radio on 9-25-11 and 1-1-12.

Dr.Kapoor-Don-Jan-1_2012.wav

Jets-Vs-Raiders-Pregame-Show-Interview-DrKapoor.mp3

Castle Connolly’s team of researchers use a rigorous screening process to select the doctors on a regional and national level. Careful screening of doctors’ educational and professional experience is essential to the committee.

The doctors are:  
 

Dr. Anthony Bruno	Dr. Barry Shepard	Dr. Robert Sunshine
Dr. Jeffrey Layne	Dr. Elliott Lieberman	Dr. Michael Ziegelbaum
Dr. Brett Mellinger

“We are very pleased that the New York Mets are taking this opportunity to build awareness about the most common cancer in men in the United States,” said Dr. Eric Mitchnick, Board President of IMF. “Selecting AUCNY and Dr. Barnswell was a natural fit. AUCNY is the largest urology group practice in the country and Dr. Barnswell is one of the most philanthropic doctors in the region, particularly in the African American community.”

Dr. Barnswell’s practice, Advanced Urology Center of New York – Elmont, provides state of the art urologic care to patients from the community and around the world. Dr. Barnswell is a recognized expert in his field and lectures extensively on prostate cancer, voiding dysfunction and men’s sexual health. He also participates in national advisory boards and has made considerable contributions to clinical research. Dr. Barnswell’s community outreach includes providing internships to high school and college students with interests in the health professions, as well as mentoring services to individuals living in underserved communities. Dr. Barnswell provides free prostate cancer screenings, education, and increases prostate cancer awareness in the African American community, particularly in the Haitian and Caribbean areas throughout the Tri-State Area. In addition to his individual efforts, he contributes his time and expertise to assist numerous non-profit and community organizations in their missions as well.

“Prostate cancer awareness is crucial in that the early detection of this common cancer because it is almost always treatable if caught early enough,” said Dr. Barnswell. “I am honored to participate in the Mets’ Prostate Cancer Awareness Day and I hope this further serves to educate individuals, particularly African-American men who are at the most jeopardy to develop this disease, on risk factors, detection and treatment options.”

IMF’s mission is to improve healthcare through patient education and community outreach. IMF is a nonprofit organization which provides free educational and outreach programs, as well as free cancer screenings and patient support groups consistent with the health care needs of the community. IMF will strive to exceed the expectations of those it serves and maintain standards of the highest quality while promoting awareness, early detection and support services. For more information call 631-247-0100 or visit http://www.imfcares.com

“By collecting self-reported patient data gathered during an automated check-in process, we expect to gather more in-depth information, while streamlining workflow for our staff,” said W. Price Dunaway, COO of IMP. “Real-time data collection and detailed patient health surveys will enable our providers to better address additional preventative care issues, further enhancing patient care.”

As patients arrive for an appointment at an IMP office, they check-in at a self-service kiosk or tablet, which prompts them to enter demographic and insurance information. Co-pays and any outstanding balances may also be collected at that time. Patients then receive material addressing their specific health risks, preventative screening details and health-related surveys, which are filled out directly on the screen.

Real-time technology allows for the patient’s information to be directly integrated into the group’s electronic health record and other systems. Following, the physician can review and assess the data before the patient encounter, enabling more meaningful patient-provider interaction. For example, an older male patient may be reminded that he is overdue for his prostate cancer screening, which can then be addressed the during the exam.

For providers and payers, this approach enables both parties to obtain the patient assessment earlier, resulting in better tracking of patient-specific details that are imperative for quality reporting requirements and pay-for-performance measures. This real-time interaction also provides an opportunity for patients to receive targeted health information and educational materials.

“As a pioneer in technology, IMP’s decision to utilize self-service applications continues to position them as a thought leader in their field. The group’s approach will not only empower its patients to take charge of managing their health, but also help its more than 100 physicians and a number of payers receive valuable patient information quickly and easily,” said Raj Toleti, CEO of PatientPoint. “Implementing a process that benefits providers, payers and patients ultimately leads to savings for all and is imperative as the healthcare industry strives to improve the quality of care.”

About Integrated Medical Professionals, PLLC

Integrated Medical Professionals, PLLC, provides diagnostic and therapeutic services to patients in the greater New York Metropolitan area. With over 100 physicians, IMP is the largest urology group in the country serving patients the highest level of care through integration of surgical specialists at the point of patient contact. For more information, visit.

http://www.imppllc.com/?inc=about&p=about

About PatientPoint™

PatientPoint™ provides self-service solutions and end-to-end billing services that enable physician practices to streamline administrative and clinical workflow, expedite revenue collection, conduct real-time claims adjudication and improve financial performance, including online pre-registration, patient check-in, scheduling, bill payment and mobile charge capture applications. The company also offers health IT consulting services to individual practices and regional extension centers. For more information, visit www.patientpointkiosk.com.

The Society of Uroradiology is organized to promote interest and investigation in the advancement of urinary and genital tract imaging, and to stimulate the study of both normal and abnormal processes. The organization’s emphasis is the integration of current imaging and interventional practice. Membership is offered to physicians and other scientists who have an interest in the practice, teaching, or research of genitourinary imaging. The conference was held March 20 – 25, 2011 at the Park Hyatt Aviara Resort in Carlsbad, California.

Dr. Mendrinos’ abstract looked at how predictable the aggressiveness of prostate cancer is via biopsy, MRI and subsequent prostatectomy (surgical removal of all or part of the prostate gland). Patients who had a positive biopsy result were given an MRI, followed by a prostatectomy. Dr. Mendrinos mapped out the entire prostatectomy specimens and cataloged the Gleason score (rating system which tells how closely a prostate tumor resembles normal prostate tissue; the lower the number, the lower grade the cancer). Dr. Mendrinos’ findings were compared to the patient’s pre-prostatectomy MRI and biopsy.  He found that visible tumors were those larger than 6mm with a persistent growth of dense fibrous tissue around the tumor, and a Gleason score of 7 and higher. Tumors with a Gleason score of 6 were not visible by MRI, unless they were larger than 6mm with aggressive activity in the fibrous tissue surrounding it.

This study’s significance is that the aggressive and clinically important tumors can be detected by doing a post or even a pre-biopsy MRI in clinically high risk patients. If the post biopsy MRI is negative, it is likely the disease in the prostate is low grade. This critical information can be instrumental in developing the standard of care protocols for watchful waiting vs. active treatment.

I.M.P. is using “Know Error” system produced by Diagnostic ID LLC. which provides DNA confirmation between patient and their biopsy tissue sample ensuring that when patients biopsy results arrive, the results are of the tested patient.

The system’s testing sequence includes a comparison of short tandem repeat, or STR, profiles of both the patient and the biopsy sample cells.

The error-elimination system is designed for prostate cancer and breast cancer biopsy samples.

“Before a biopsy procedure, a reference sample of the patient’s DNA is taken by swabbing the inside of the patient’s cheek. The swab is sent to an independent forensic DNA lab,” the company said.

If biopsy results come back positive, DNA from the biopsy is double-checked against DNA from the patient cheek swab.

Integrated Medical Professionals is headquartered in Melville, NY. Dr. Deepak Kapoor is Chairman and Chief Executive Officer, IMP has offices in Long Island NY, Westchester, Bronx and Brooklyn.

Recently many urologists from IMP were selected as among the top urologists in NY.